NCT06253962 Carotid Atherosclerosis in Predicting Coronary Artery Disease
| NCT ID | NCT06253962 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Zhongshan Hospital |
| Condition | Carotid Atherosclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-02-10 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-02-10 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Carotid plaque burden and composition features, particularly lipid necrotic core, are significantly associated with severity of CAD stenosis. This study aims to explore the relationship between various phenotypic patterns of carotid atherosclerosis with the prevalence, phenotype, and severity of coronary atherosclerosis. The patients with chest tightness or chest pain will receive carotid artery ultrasonography before coronary angiography so as to explore the relationship between them.
Eligibility Criteria
Inclusion Criteria: * patients receive carotid ultrasound and coronary angiography Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06253962 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 90 Years, studying Carotid Atherosclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06253962 currently recruiting?
Yes, NCT06253962 is actively recruiting participants. Contact the research team at lu.danbo@zs-hospital.sh.cn for enrollment information.
Where is the NCT06253962 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06253962 clinical trial?
NCT06253962 is sponsored by Shanghai Zhongshan Hospital. The trial plans to enroll 1,000 participants.